Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 17, 2013

Aethersys, Amgen, Amneal, Aquinox, ArGEN-X, Asmacure, Boehringer Ingelheim, Hanmi, Ipsen, RedHill Biopharma, Sucampo, Takeda

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I ArGEN-X hits dose escalation goals . . . read more Phase II Aquinox begins COPD trial . . . read more Asmacure advances lead lung compound . . . read more Phase III Amgen MAb reduces LDL-C . . . read more BI drug hits endpoint in VTE trial . . . read more Ipsen’s Dysport posts positive results in spasticity trial . . . read more RedHill begins dosing gastritis trial . . . read more Sucampo, Takeda begin constipation trials . . . read more Filings Aethersys gets Orphan statu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters